Drugs modulating the levels of specific central neurotransmitters may influ
ence both the rate and amount of functional recovery after focal brain inju
ries such as stroke. Because such drugs may be effective long after brain i
njury, the "therapeutic window" may be widened beyond the first few hour af
ter stroke and an entirely new avenue for pharmacological intervention may
be possible. The impact of drugs affecting norepinephrine and gamma-aminobu
tyric acid have been among the mast extensively studied in the laboratory,
and preliminary clinical data suggest similar effects in humans. Published
by Elsevier Science Ltd.